| Dr Andrew Hammer, MD | |
|
Walter Reed Army Medical Ctr, Eye Clinic, 1f, Washington, DC 20307-0001 | |
| (202) 782-6965 | |
| Not Available |
| Full Name | Dr Andrew Hammer |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 19 Years |
| Location | Walter Reed Army Medical Ctr, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720281181 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 0101241582 (Virginia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Visionary Ophthalmology Llc | 4587795687 | 14 |
News Archive
A team of researchers at City of Hope has developed a screening assay that can quickly assess up to 1,536 compounds' effect on estrogen activity in the body. The test can also evaluate whether chemicals act as inhibitors of aromatase, an enzyme linked to breast cancer that converts androgen to estrogen.
A mutant rat that mimics a 400-pound human is helping scientists understand early vascular changes that make walking a pain for more than 2 million Americans.
nSpire Health, LLC, a leading provider of respiratory diagnostic devices and clinical trial services, issued audited results for 2010 today. Sales of $27.6M are up 3% year over year. The Company reported a $3.6M improvement in EBIT when compared to 2009 and its highest profit since the founding of the company in 2006. Cash is up $2.4M and debt reduced to less than $400K.
A shorter course of higher-dose radiation treatment to part of the breast is showing promise in women with early-stage breast cancer who undergo breast conserving surgery, says a study led by Hamilton researchers.
Mylan Inc. today announced that its subsidiary Mylan Technologies Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Clonidine Transdermal System USP, 0.1 mg/day, 0.2 mg/day and 0.3 mg/day, the generic version of Boehringer Ingelheim's Catapres-TTS®, a treatment for hypertension.
› Verified 4 days ago
| Entity Name | Visionary Ophthalmology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952595084 PECOS PAC ID: 4587795687 Enrollment ID: O20100707000311 |
News Archive
A team of researchers at City of Hope has developed a screening assay that can quickly assess up to 1,536 compounds' effect on estrogen activity in the body. The test can also evaluate whether chemicals act as inhibitors of aromatase, an enzyme linked to breast cancer that converts androgen to estrogen.
A mutant rat that mimics a 400-pound human is helping scientists understand early vascular changes that make walking a pain for more than 2 million Americans.
nSpire Health, LLC, a leading provider of respiratory diagnostic devices and clinical trial services, issued audited results for 2010 today. Sales of $27.6M are up 3% year over year. The Company reported a $3.6M improvement in EBIT when compared to 2009 and its highest profit since the founding of the company in 2006. Cash is up $2.4M and debt reduced to less than $400K.
A shorter course of higher-dose radiation treatment to part of the breast is showing promise in women with early-stage breast cancer who undergo breast conserving surgery, says a study led by Hamilton researchers.
Mylan Inc. today announced that its subsidiary Mylan Technologies Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Clonidine Transdermal System USP, 0.1 mg/day, 0.2 mg/day and 0.3 mg/day, the generic version of Boehringer Ingelheim's Catapres-TTS®, a treatment for hypertension.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Hammer, MD 8560 2nd Ave Apt 811, Silver Spring, MD 20910-6308 Ph: () - | Dr Andrew Hammer, MD Walter Reed Army Medical Ctr, Eye Clinic, 1f, Washington, DC 20307-0001 Ph: (202) 782-6965 |
News Archive
A team of researchers at City of Hope has developed a screening assay that can quickly assess up to 1,536 compounds' effect on estrogen activity in the body. The test can also evaluate whether chemicals act as inhibitors of aromatase, an enzyme linked to breast cancer that converts androgen to estrogen.
A mutant rat that mimics a 400-pound human is helping scientists understand early vascular changes that make walking a pain for more than 2 million Americans.
nSpire Health, LLC, a leading provider of respiratory diagnostic devices and clinical trial services, issued audited results for 2010 today. Sales of $27.6M are up 3% year over year. The Company reported a $3.6M improvement in EBIT when compared to 2009 and its highest profit since the founding of the company in 2006. Cash is up $2.4M and debt reduced to less than $400K.
A shorter course of higher-dose radiation treatment to part of the breast is showing promise in women with early-stage breast cancer who undergo breast conserving surgery, says a study led by Hamilton researchers.
Mylan Inc. today announced that its subsidiary Mylan Technologies Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Clonidine Transdermal System USP, 0.1 mg/day, 0.2 mg/day and 0.3 mg/day, the generic version of Boehringer Ingelheim's Catapres-TTS®, a treatment for hypertension.
› Verified 4 days ago
Dr. Saima M Qureshi, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2041 Georgia Ave Nw, Washington, DC 20060 Phone: 202-865-6100 | |
Melanie J Buttross, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4910 Massachusetts Ave Nw, Ste 21, Washington, DC 20016 Phone: 202-686-6700 Fax: 202-537-1442 | |
Dr. Bilal Khan Yousufzai, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw, Dept Of Ophthalmology, Washington, DC 20010 Phone: 202-877-5658 Fax: 202-877-7743 | |
Dr. Marc Jay Holzman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2021 K St Nw, Suite 416, Washington, DC 20006 Phone: 202-296-1333 Fax: 202-296-9357 | |
Dr. Bethany A Karwoski, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-476-5000 | |
Kelly Hutcheson, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 111 Michigan Ave Nw, Washington, DC 20010 Phone: 202-884-3015 | |
Dr. Reginald Dacosta Barnes Jr., M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2112 F St Nw Ste 802, Washington, DC 20037 Phone: 202-331-1757 Fax: 202-331-1757 |